期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 8, 期 10, 页码 1643-1650出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.8.10.1643
关键词
chemoembolization; drug-eluting embolization agent; HCC; hepatocellular carcinoma; locoregional percutaneous treatment; particulate embolization material; TACE; transcatheter arterial chemoembolization
类别
The advantage of chemoembolization of the liver as an antineoplastic treatment for hepatocellular carcinoma is that it achieves high intratumoral concentrations of the chemotherapeutic agent locally that cannot be reached with systemic chemotherapy in nontoxic doses. However, chemotherapeutic release and local concentrations cannot be standardized by this technique. Drug-eluting beads have predictable pharmacokinetics and can achieve higher doses of the chemotherapeutic and prolonged contact time with cancer cells. The DC Bead (TM) is a drug-eluting bead that has proven favorable kinetics and clinical characteristics. This review describes the features of the DC Bead loaded with doxorubicin for the treatment of hepatocellular carcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据